{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/67e45a3f99bc2367f423e9f2/685c2d1b0904b52e467344de?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Immune-Priviliged Cells Scaled for Treatments with Yuta Lee","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/67e45a3f99bc2367f423e9f2/1750871154814-e0aa6d49-f52b-422d-aa5a-de6e6a2d1846.jpeg?height=200","description":"<p>The Future of Stem Cell Therapy</p><p><br></p><p>In this conversation, Yuta Lee shares his journey from economics and law to the forefront of stem cell therapy and longevity research. He discusses the potential of stem cells and gene therapy in curing diseases and extending healthspan. Yuta explains the significance of exosomes in cell communication and their role in rejuvenating aging cells. He emphasizes the importance of immune privilege in stem cell therapies and the need for regulatory changes to support preventive healthcare. The conversation highlights the collaborative spirit in the longevity field and the vision for democratizing access to advanced therapies.</p><p><br></p><p><br></p>","author_name":"Longevity Summit Dublin"}